Lighting the way: New leaders in the fourth industrial revolution
July 3, 2019
Biotechnology firm Zymergen brought robotics and artificial intelligence (AI) to bioengineering labs, traditionally highly manual sites. Innovation rates soared, allowing Zymergen to use bioengineering for products previously were not feasible.
Zymergen’s Opportunity to Drive the Fourth Industrial Revolution through Biology
Mar 9, 2020
by Josh Hoffman, CEO, Zymergen
The World Economic Forum and McKinsey recently published a whitepaper in which they recognize Zymergen as a “lighthouse company”, in implementing the Fourth Industrial Revolution technologies.
The world of petroleum-based material development and manufacturing is experiencing a significant innovation lull; fewer new ideas, fewer areas for improvement, and a finite raw material resource that’s running out quickly. Bio-based manufacturing is the answer and it will create the next industrial revolution.
Zymergen is bringing the best of pure technology, automation, and biological experimentation together in a single platform and thus transforming the way things are made.
At Zymergen, our view is that biological system of the universe or earth itself is the world’s greatest manufacturing system. So we partner with nature to create and commercialize revolutionary new materials. We developed a unique technology platform that combines biology, machine learning, and automation to develop the largest library of proprietary genomic data in the world, and we use that information to discover, design and scale in a way no other company can. As a result, we can bring new products to market in half the time and for one-tenth the cost of companies that use petrochemical-based materials. And the applications are incredibly broad: from electronics to adhesives to agriculture products — and more. There are loads of benefits to our approach, including lower cost, shorter time to market and dramatically lower environmental footprint. But at the end of the day, we’re actually making better products, and that’s a key difference between our team and others in this emerging space.
Our team fuses deep biology, chemistry, and computer science expertise. We invested in creating an automated, high-throughput biomanufacturing system that can be reconfigured in minutes and can scale to fill a factory, bringing the best of pure technology, automation, and biological experimentation together in a single platform that is wholly transforming the way things are made.
In the time we’ve been in operation, we have realized a 40% increase in our production yield and a 50% reduction in lead time, all while lowering our operating costs by 42% — simply by optimizing our capacity, inventory and teams.
Pdf files
https://partnershiponai.org/wp-content/uploads/2021/08/Case-Study_Zymergen.pdf
https://www.appengine.ai/company/zymergen
https://www.linkedin.com/pulse/bioengineering-revolution-maria-marenco
https://www.linkedin.com/pulse/top-10-ai-startups-2020-healthcare-clinical-trail-ganapathy-shankar
https://www.sumitomo-chem.co.jp/english/news/detail/20190417e.html
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944054/
https://www.ginkgobioworks.com/
https://www.nature.com/articles/s41467-020-20122-2
https://www.forbes.com/sites/johncumbers/2020/06/05/how-california-can-lead-the-global-bioeconomy-a-conversation-with-zymergen-ceo-josh-hoffman/?sh=57481c56a64a
https://glasp.co/youtube/p/zymergen-ceo-josh-hoffman-on-biofacturing-plus-founderu-startup-math-e1231
https://ecorner.stanford.edu/podcasts/insights-of-an-accidental-entrepreneur/
I know nothing of the industries needed, but I do love lighthouses! Fun to tour! Congratulations on completing the A to Z.
ReplyDelete